The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global BCG Tuberculosis (TB) Vaccine Market Research Report 2025
Synopsis
BCG Tuberculosis (TB) Vaccine is a vaccine primarily used against tuberculosis.
The global BCG Tuberculosis (TB) Vaccine market was valued at US$ 30 million in 2023 and is anticipated to reach US$ 36 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for BCG Tuberculosis (TB) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG Tuberculosis (TB) Vaccine.
Report Scope
The BCG Tuberculosis (TB) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global BCG Tuberculosis (TB) Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BCG Tuberculosis (TB) Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Segment by Type
Immune BCG
Therapy BCG
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of BCG Tuberculosis (TB) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of BCG Tuberculosis (TB) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
BCG Tuberculosis (TB) Vaccine is a vaccine primarily used against tuberculosis.
The global BCG Tuberculosis (TB) Vaccine market was valued at US$ 30 million in 2023 and is anticipated to reach US$ 36 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for BCG Tuberculosis (TB) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG Tuberculosis (TB) Vaccine.
Report Scope
The BCG Tuberculosis (TB) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global BCG Tuberculosis (TB) Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BCG Tuberculosis (TB) Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Segment by Type
Immune BCG
Therapy BCG
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of BCG Tuberculosis (TB) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of BCG Tuberculosis (TB) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 BCG Tuberculosis (TB) Vaccine Market Overview
1.1 Product Overview and Scope of BCG Tuberculosis (TB) Vaccine
1.2 BCG Tuberculosis (TB) Vaccine Segment by Type
1.2.1 Global BCG Tuberculosis (TB) Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Immune BCG
1.2.3 Therapy BCG
1.3 BCG Tuberculosis (TB) Vaccine Segment by Application
1.3.1 Global BCG Tuberculosis (TB) Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global BCG Tuberculosis (TB) Vaccine Market Size Estimates and Forecasts
1.4.1 Global BCG Tuberculosis (TB) Vaccine Revenue 2019-2030
1.4.2 Global BCG Tuberculosis (TB) Vaccine Sales 2019-2030
1.4.3 Global BCG Tuberculosis (TB) Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 BCG Tuberculosis (TB) Vaccine Market Competition by Manufacturers
2.1 Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global BCG Tuberculosis (TB) Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global BCG Tuberculosis (TB) Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of BCG Tuberculosis (TB) Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of BCG Tuberculosis (TB) Vaccine, Product Type & Application
2.7 BCG Tuberculosis (TB) Vaccine Market Competitive Situation and Trends
2.7.1 BCG Tuberculosis (TB) Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest BCG Tuberculosis (TB) Vaccine Players Market Share by Revenue
2.7.3 Global BCG Tuberculosis (TB) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 BCG Tuberculosis (TB) Vaccine Retrospective Market Scenario by Region
3.1 Global BCG Tuberculosis (TB) Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global BCG Tuberculosis (TB) Vaccine Global BCG Tuberculosis (TB) Vaccine Sales by Region: 2019-2030
3.2.1 Global BCG Tuberculosis (TB) Vaccine Sales by Region: 2019-2024
3.2.2 Global BCG Tuberculosis (TB) Vaccine Sales by Region: 2025-2030
3.3 Global BCG Tuberculosis (TB) Vaccine Global BCG Tuberculosis (TB) Vaccine Revenue by Region: 2019-2030
3.3.1 Global BCG Tuberculosis (TB) Vaccine Revenue by Region: 2019-2024
3.3.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Region: 2025-2030
3.4 North America BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country
3.4.1 North America BCG Tuberculosis (TB) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America BCG Tuberculosis (TB) Vaccine Sales by Country (2019-2030)
3.4.3 North America BCG Tuberculosis (TB) Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country
3.5.1 Europe BCG Tuberculosis (TB) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe BCG Tuberculosis (TB) Vaccine Sales by Country (2019-2030)
3.5.3 Europe BCG Tuberculosis (TB) Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific BCG Tuberculosis (TB) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific BCG Tuberculosis (TB) Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific BCG Tuberculosis (TB) Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Indonesia
3.6.10 Thailand
3.6.11 Malaysia
3.6.12 Philippines
3.6.13 Vietnam
3.7 Latin America BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country
3.7.1 Latin America BCG Tuberculosis (TB) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America BCG Tuberculosis (TB) Vaccine Sales by Country (2019-2030)
3.7.3 Latin America BCG Tuberculosis (TB) Vaccine Revenue by Country (2019-2030)
3.7.4 Brazil
3.8 Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa BCG Tuberculosis (TB) Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 GCC Countries
3.8.6 Egypt
3.8.7 South Africa
4 Segment by Type
4.1 Global BCG Tuberculosis (TB) Vaccine Sales by Type (2019-2030)
4.1.1 Global BCG Tuberculosis (TB) Vaccine Sales by Type (2019-2024)
4.1.2 Global BCG Tuberculosis (TB) Vaccine Sales by Type (2025-2030)
4.1.3 Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Type (2019-2030)
4.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Type (2019-2030)
4.2.1 Global BCG Tuberculosis (TB) Vaccine Revenue by Type (2019-2024)
4.2.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Type (2025-2030)
4.2.3 Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global BCG Tuberculosis (TB) Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global BCG Tuberculosis (TB) Vaccine Sales by Application (2019-2030)
5.1.1 Global BCG Tuberculosis (TB) Vaccine Sales by Application (2019-2024)
5.1.2 Global BCG Tuberculosis (TB) Vaccine Sales by Application (2025-2030)
5.1.3 Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2019-2030)
5.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Application (2019-2030)
5.2.1 Global BCG Tuberculosis (TB) Vaccine Revenue by Application (2019-2024)
5.2.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Application (2025-2030)
5.2.3 Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global BCG Tuberculosis (TB) Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck BCG Tuberculosis (TB) Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Japan BCG Lab
6.3.1 Japan BCG Lab Corporation Information
6.3.2 Japan BCG Lab Description and Business Overview
6.3.3 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product Portfolio
6.3.5 Japan BCG Lab Recent Developments/Updates
6.4 China National Biotec
6.4.1 China National Biotec Corporation Information
6.4.2 China National Biotec Description and Business Overview
6.4.3 China National Biotec BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 China National Biotec BCG Tuberculosis (TB) Vaccine Product Portfolio
6.4.5 China National Biotec Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Serum Institute of India BCG Tuberculosis (TB) Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Intervax
6.6.1 Intervax Corporation Information
6.6.2 Intervax Description and Business Overview
6.6.3 Intervax BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Intervax BCG Tuberculosis (TB) Vaccine Product Portfolio
6.6.5 Intervax Recent Developments/Updates
6.7 GSBPL
6.6.1 GSBPL Corporation Information
6.6.2 GSBPL Description and Business Overview
6.6.3 GSBPL BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GSBPL BCG Tuberculosis (TB) Vaccine Product Portfolio
6.7.5 GSBPL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 BCG Tuberculosis (TB) Vaccine Industry Chain Analysis
7.2 BCG Tuberculosis (TB) Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 BCG Tuberculosis (TB) Vaccine Production Mode & Process
7.4 BCG Tuberculosis (TB) Vaccine Sales and Marketing
7.4.1 BCG Tuberculosis (TB) Vaccine Sales Channels
7.4.2 BCG Tuberculosis (TB) Vaccine Distributors
7.5 BCG Tuberculosis (TB) Vaccine Customers
8 BCG Tuberculosis (TB) Vaccine Market Dynamics
8.1 BCG Tuberculosis (TB) Vaccine Industry Trends
8.2 BCG Tuberculosis (TB) Vaccine Market Drivers
8.3 BCG Tuberculosis (TB) Vaccine Market Challenges
8.4 BCG Tuberculosis (TB) Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
